New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:10 EDTNEONeoGenomics validates and launches new detection test for the CALR gene
NeoGenomics announced that it has validated and launched a new test for the detection of mutations in the calreticulin, or CALR, gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms for the first time at the annual meeting of the American Society of Hematology last month. Since then, findings on the CALR gene have been published in the three articles referenced below.
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NEO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use